The analysis revealed that there were no significant differences in STAT3 expression between TNBC and non-TNBC patients, suggesting that targeting STAT3 for breast cancer treatment could theoretically be effective in both TNBC and non-TNBC patients. This evidence concerns the gene STAT3 and breast cancer.